ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Antioxidant treatment could halt neurodegeneration in early Parkinson's

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

Low vitamin D levels predict ED in diabetics

 
Print Page
Email Article

Unique IBS gut flora ‘signature’ identified; may lead to better diagnostics, treatments

  [ 22 votes ]   [ Discuss This Article ]
www.ProHealth.com • August 12, 2011


Article:
Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples from Patients with Irritable Bowel Syndrome – Source: Gastroenterology, Aug 4, 2011

By M Fajilic-Stojanovic, W M de Vos, et al.

Background & Aims: Irritable bowel syndrome (IBS) has been associated with disruptions to the intestinal microbiota, but studies have had limited power, coverage, and depth of analysis. We aimed to define microbial populations that can be used to discriminate the fecal microbiota of patients with IBS from that of healthy subjects and correlate these with IBS intestinal symptom scores.

Methods: The microbiota composition was assessed by global and deep molecular analysis of fecal samples from 62 patients with IBS patients and 46 healthy individuals (controls). We used a comprehensive and highly reproducible phylogenetic microarray in combination with quantitative PCR.

Results:

The intestinal microbiota of IBS patients differed significantly ( P =.0005) from that of controls. [That is, the odds of this difference resulting by chance are 1 in 100,000.]

The microbiota of patients, compared with controls, had a 2-fold increased ratio of the Firmicutes to Bacteroidetes ( P =.0002). [Note: other studies have associated an elevated proportion of Firmicutes with the elderly GI tract, which in turn is typically linked to reduced digestive secretions, slower gut transit time, reduced energy production and weight gain.]

This resulted from:

• An approximately 1.5-fold increase in numbers of Dorea, Ruminococcus, and Clostridium spp. ( P <.005); [Types of Firmicutes]

• A 2-fold decrease in the number of Bacteroidetes ( P <.0001);

• A 1.5-fold decrease in numbers of Bifidobacterium and Faecalibacterium spp. ( P <.05); [Bifidobacteria are considered helpful ‘probiotics’ and faecalibacteria have an anti-inflammatory effect.]

• And, when present, a 4-fold lower average number of methanogens (3.50x10(7) vs 8.74x10(6) cells/g feces; P =.003). [Methanogens are involved in the production of ATP – the fuel that the mitochondria burn to produce cellular energy.]

Correlation analysis of the microbial groups and IBS symptom scores indicated the involvement of several groups of Firmicutes and Proteobacteria in the pathogenesis of IBS. [Proteobacteria are gram-negative bacteria, including many that are pathogenic.]

Conclusions:

• Global and deep molecular analysis of fecal samples indicates that patients with IBS have a different composition of microbiota.

• This information might be used to develop better diagnostics and ultimately treatments for IBS.

Source: Gastroentrology, Aug 4, 2011. PMID: 21820992, by Rajili?-Stojanovi? M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands; Department for Biotechnology and Biochemical Engineering, Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia; Departments of Veterinary Biosciences and Bacteriology & Immunology, University of Helsinki, Finland. [Email: willem.devos@wur.nl]




Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Optimized Curcumin Longvida® Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep? Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep?
Breaking Through the Mental Fog Breaking Through the Mental Fog
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Natural Bladder Control, Go Less and Live More Natural Bladder Control, Go Less and Live More
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map